were associated with ISR. Conclusions: This study suggests that ISR is not associated with baseline coronary plaque composition but is associated with old age and increased expression of the inflammatory marker of hs-CRP. (Cardiol J 2018; 25, 1: 7-13) 
Introduction
Over recent decades, percutaneous coronary intervention (PCI) techniques have improved extraordinarily. In particular, the introduction of the drug-eluting stent (DES) reduced the prevalence of in-stent restenosis (ISR) and the re-intervention rate compared to the bare-metal stent. Rates of target lesion revascularization were as high as 20% with the bare metal stent compared to the single-digit rates with DES [1, 2] . However, despite the extensive introduction of DESs, ISR did not disappear and is still causing problems in high-risk patients and complex lesions [3] [4] [5] .
The mechanisms involved in ISR include biological, mechanical, and technical factors. The mechanical and technical factors related to ISR can be overcome by using new-generation polymer-free DESs, intracoronary imaging and/or high-pressure ballooning, which eliminate stent malapposition, total lesion coverage, and stent edge dissection. Inflammation, which is an important mechanism of atherosclerosis, is also known as an important factor in the restenosis process. The inflammatory process includes platelet deposition, leukocyte recruitment, and smooth muscle cell migration and proliferation [6, 7] . These inflammatory processes were seen in human and rabbit models after stenting. Inflammation after stenting in human was more profound in damaged media in contact with the stent. In addition, the inflammatory cytokine CD 11b was increased in patients with restenosis [8] .
Therefore, we hypothesized that a greater inflammatory reaction at the culprit lesion may lead to higher restenosis rates. The objective of this study was to compare plaque composition, which represents plaque inflammatory status, in patients with ISR and those without ISR.
Methods

Study population
The study population consisted of 331 consecutive patients of PCI and virtual histology-intravascular ultrasound (VH-IVUS) at the Konyang University Hospital. Ninety patients were excluded because they did not undergo the 9-month followup coronary angiography (CAG) mainly due to no subjective symptoms and inconvenience. A total of 241 patients who underwent PCI with stenting and VH-IVUS as well as the 9-month follow-up CAG were enrolled in this study. An ISR was defined as the presence of over 50% diameter stenosis by visual assessment in the stented lesion [9] . Twenty-seven (11.2%) patients had ISR, whereas 214 (88.8%) patients showed no ISR. The angiographic findings were reviewed by two blinded cardiologists. Another cardiologist gave an opinion if the 2 cardiologists disagreed about the ISR.
Demographic data of the study population were confirmed by chart review. Coronary risk factors included hypertension (blood pressure ≥ 140/90 mm Hg based on the average of repeated readings or the presence of antihypertensive drug therapy), dyslipidemia (total cholesterol > 200 mg/dL and/or triglyceride > 150 mg/dL and/or low-density lipoprotein cholesterol > 130 mg/dL or patients on lipid-lowering therapy), diabetes mellitus (controlled with diet, oral hypoglycemic agents, or insulin, fasting glucose levels ≥ 126 mg/dL, or 2 h oral glucose tolerance test ≥ 200 mg/dL), and current cigarette smoking. This study was approved by the ethics committee of the Konyang University Hospital and was in accordance with the Declaration of Helsinki.
PCI
All patients received 300 mg aspirin, 300-600 mg clopidogrel, and 120 IU/kg of unfractionated heparin intravenously before PCI. PCI was performed via the radial or femoral approach using 5, 6 or 7 Fr guiding catheter and 0.014-inch standard or extra-support coronary guidewires. The culprit lesion was identified by ventricular wall motion abnormalities and the appearance of the angiographic lesion. All study subjects underwent successful PCI at the culprit lesion and VH-IVUS examination.
IVUS examination and analysis
VH-IVUS examination was performed on the culprit lesion with a dedicated 20-MHz, 2.9 F monorail, electronic Eagle Eye Gold IVUS catheter (Volcano Therapeutics, Rancho Cordova, California) and VH-IVUS console (Volcano Therapeutics, Rancho Cordova, California) during the CAG after intracoronary administration of 100-200 µg nitroglycerin. The IVUS catheter was advanced into the target lesion after wiring or ballooning and an automatic pullback at 0.5 mm/s was done. The VH-IVUS image was recorded on a DVD-ROM for offline analysis.
Both qualitative and quantitative analyses of grayscale IVUS images were performed according to the criteria of the American College of Cardiology's Clinical Expert Consensus Document on IVUS [10] [11] [12] . The proximal and distal references were defined as the sites with the largest lumen that were proximal and distal to the stenosis but within the same segment (usually within 10 mm of the stenosis with no major intervening branches), respectively.
The cross-sectional area (CSA) of the external elastic membrane (EEM) was measured with customized software (IVUS lab., Volcano Therapeutics, Rancho Cordova, CA, USA). The remodeling index was calculated as the lesion EEM CSA divided by the average reference EEM CSA.
Spectral analysis of the IVUS radiofrequency data
The following analyses were conducted on the target lesion with customized software (IVUS Lab.; Volcano Therapeutics, Rancho Cordova, California) by an examiner who was unaware of the grayscale IVUS results. For both the lumen and the mediaadventitia interface, automatic border detection Duck-Jun Seo et al., Impact of inflammation on coronary in-stent restenosis was done at the predefined lesion segment. The border detection was manually corrected in the lesion after automatic border detection. Border detection required the agreement of two independent experienced cardiologists (KTG and PHW). Disagreements were reviewed by a third cardiologist (BJH). After confirming the border detection, the software automatically calculated and showed the results. For each frame, the histologic findings were expressed in colors (green for fibrous, green-yellow for fibro-fatty, white for dense calcified, and red for necrotic core area). The predictive accuracy of this method with tissue mapping has been validated [13] . The area (mm 2 ) and percent area of each tissue component of the plaque were analyzed at the minimal luminal area site, and the volume (mm 3 ) and the percent volume of each tissue component of the plaque were evaluated at a full segment of the culprit lesion. Volume was divided by lesion length to adjust for the different lesion lengths of each patient, and this was reported as the corrected volume (mm 3 /mm).
Statistical analysis
All analyses were performed with SPSS (version 18.0; SPSS Inc., Chicago, Illinois). All data were expressed as the mean ± standard deviation for continuous variables and as percentage ratios for categorical variables. Categorical variables were compared by the c 2 test. Continuous variables were compared by independent t-tests. Binary logistic regression analyses were performed to determine the independent factors for ISR. A p value < 0.05 was considered statistically significant.
Results
Demographics
The patients with ISR (n = 27, 11.2%) were likely to be older (66.2 ± 9.5 years old vs. 58.7 ± ± 11.7 years old, p = 0.002) and have higher highsensitivity C-reactive protein (hs-CRP) expression (1.60 ± 3.59 mg/dL vs. 0.31 ± 0.76 mg/dL, p < 0.001) than those without ISR (n = 214, 88.8%). In addition, patients with ISR were more likely to take beta-blockers (88.9% vs. 70.0%, p = 0.046) than those without ISR. Other demographic findings, such as risk factors, medication and other blood chemistry, showed no significant differences between the two groups ( Table 1) .
Angiographic findings also showed no significant differences between the two groups in terms of treated vessel, inserted stent type, length and diameter (Table 2) .
IVUS findings
Grayscale IVUS findings also showed no significant differences between the two groups (Table 3) . Baseline volumetric VH-IVUS findings over the lesion length showed smaller necrotic core volume (14.2 ± 12.7 mm 3 vs. 22.1 ± 19.9 mm 3 , p = 0.045) and percent necrotic core volume (14.3 ± 8.7% vs. 19.5 ± 9.1%, p = 0.005) in patients with ISR compared to those without ISR by univariate analysis. However, percent fibrofatty volume was larger (16.6 ± 9.7% vs. 12.4 ± 8.4%, p = 0.018) by univariate analysis in patients with ISR than in those without ISR. Baseline lesion analysis at the minimal luminal area showed no significant differences between the two groups ( Table 4) . Fibrocalcific atheroma was the most frequent lesion type (n = 10, 37.0%) in patients with ISR, whereas thin cap fibroatheroma (n = 103, 48.1%) was the most common type in those without ISR.
Independent factors for ISR
Binary logistic regression analyses showed that the VH-IVUS findings did not have any significant impact on ISR rates in this study population. When we performed the analysis in those with acute coronary syndrome and those with stable angina, there were no significant factors for ISR. Old age and higher hs-CRP were the significant independent factors for ISR in this study (Table 5 ).
Discussion
The main findings of this study are as follows: first, old age and high inflammatory status, which was reflected by a high serum hs-CRP level, were associated with ISR in patients with DES implantation; second, baseline plaque composition did not have an impact on ISR in patients in the present study.
Introduction of the DES significantly reduced ISR due to the anti-inflammatory, immunomodulatory, and/or antiproliferative actions of coated drugs. However, ISR is still a major limitation of DESs, which is caused by biological (drug resistance and hypersensitivity), mechanical (stent underexpansion, nonuniform drug distribution, and stent fracture), and technical factors (barotraumas outside stented segment, stent gap, and residual uncovered atherosclerotic plaques) [6] . A study showed that inflammatory cytokine-associated neointimal hyperplasia resulted in granuloma formation and reactive inflammatory infiltration, which is a main etiology of ISR in stented vessels in the pig coronary restenosis model [14] . Inflammatory Cardiology Journal 2018, Vol. 25, No. 1 reaction is also important in ISR in humans. Inflammatory reaction after coronary stenting leads to vascular injury, and secondary inflammation activates smooth muscle cells to transform, migrate, and proliferate, ultimately inducing neointima formation, which contributes to coronary ISR [15] .
A recent study has also shown the association of higher and more-prolonged CRP plasma levels and ISR [16] . Moreover, the degree of initial coronary plaque inflammation, which was reflected by hs-CRP level, associated with coronary in-stent restenosis after PCI in recurrent unstable angina. ISR -in-stent restenosis; MI -myocardial infarction; ACS -acute coronary syndrome; NSTEMI -non-ST-elevation myocardial infarction; STEMI -ST-elevation myocardial infarction; ACEI -angiotensin-converting enzyme inhibitors; ARB -angiotensin receptor blockers; BBbeta-blockers; CCB -calcium channel blockers; OHA -oral hypoglycemic agents; HDL -high-density lipoprotein; LDL -low-density lipoprotein; hs-CRP -high-sensitivity C-reactive protein; FU CAG -follow-up coronary angiography; PCI -percutaneous coronary intervention
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Pathogenesis of atherosclerosis includes foam cell accumulation in the smooth muscle and endothelial cell layers after oxidation of low-density lipoprotein cholesterol by macrophages. This pathogenesis is associated with inflammatory reactions, and the death of these foam cells ultimately causes necrotic core formation [17] . Therefore, it was hypothesized that the inflammatory coronary plaque composition, such as necrotic core and lipid component in this study, may be associated with ISR development. However, this study did not reveal any significant associations between coronary plaque composition and ISR development. The inflammatory atherosclerotic process can occur naturally after coronary stenting due to increased mechanical and biological stress-induced smooth muscle cell proliferation and neointimal hyperplasia. Thus, inflammation after coronary stenting could be more important than prior plaque composition in terms of ISR. For this reason, the baseline necrotic core volume and/ /or fibrofatty component were not correlated with ISR in the multivariate analysis of this study.
A previous study revealed that old age is an etiology of ISR [18] . In this study, ISR occurred in almost twice as many patients who were over 75 years old than in patients under 75 years old (p < 0.001) and this result was explained by lower ejection frac- This multivariate analysis included age, hs-CRP, beta-blockers, % NCV and % FFV as variables; hs-CRP -high-sensitivity C-reactive protein; NCV -necrotic core volume; FFV -fibrofatty volume tions, more unstable angina, higher angina class, more ostial lesions, multivessel disease, calcified lesions and complex lesions observed in older patients. This finding is consistent with this study.
The inflammatory marker hs-CRP is known to be associated with ISR; this was also shown in our study. The increased baseline levels of acute-phase proteins are a marker for hyperresponsiveness of the inflammatory system to nonspecific stimuli [19] . After acute injury, the inflammatory response begins with vascular wall penetration of leukocytes followed by smooth muscle cell migration and hyperplasia. Finally, these processes lead to excessive neointimal hyperplasia [20] . Therefore, increased hs-CRP reflects an exaggerated response to coronary stenting and is thus is correlated with ISR in this study, whereas higher inflammatory coronary plaque composition was not.
There were several limitations in this study. At first, follow-up CAG was performed usually 9 months after PCI. This could not evaluate the ISR due to neo-atheroslcerosis, which can occur very late after stenting. Secondly, we did not evaluate post-stent IVUS and follow up IVUS examination.
